RB1CC1
RB1-inducible coiled-coil protein 1
Also known as: ATG17, Cc1, DRAGOU14, FIP200, KIAA0203, PPP1R131, RBCC1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDY2
- Gene
- RB1CC1
- Ensembl
- ENSG00000023287
- Chromosome
- 8
- Canonical length
- 1594 aa
- Protein class
- Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nuclear membrane,Cytosol
OverviewNCBI Gene
The protein encoded by this gene interacts with signaling pathways to coordinately regulate cell growth, cell proliferation, apoptosis, autophagy, and cell migration. This tumor suppressor also enhances retinoblastoma 1 gene expression in cancer cells. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Nov 2009]
Canonical amino-acid sequenceUniProt
1594 residues, UniProt reviewed canonical sequence.
>Q8TDY2|RB1CC1
1 MKLYVFLVNT GTTLTFDTEL TVQTVADLKH AIQSKYKIAI QHQVLVVNGG ECMAADRRVC
61 TYSAGTDTNP IFLFNKEMIL CDRPPAIPKT TFSTENDMEI KVEESLMMPA VFHTVASRTQ
121 LALEMYEVAK KLCSFCEGLV HDEHLQHQGW AAIMANLEDC SNSYQKLLFK FESIYSNYLQ
181 SIEDIKLKLT HLGTAVSVMA KIPLLECLTR HSYRECLGRL DSLPEHEDSE KAEMKRSTEL
241 VLSPDMPRTT NESLLTSFPK SVEHVSPDTA DAESGKEIRE SCQSTVHQQD ETTIDTKDGD
301 LPFFNVSLLD WINVQDRPND VESLVRKCFD SMSRLDPRII RPFIAECRQT IAKLDNQNMK
361 AIKGLEDRLY ALDQMIASCG RLVNEQKELA QGFLANQKRA ENLKDASVLP DLCLSHANQL
421 MIMLQNHRKL LDIKQKCTTA KQELANNLHV RLKWCCFVML HADQDGEKLQ ALLRLVIELL
481 ERVKIVEALS TVPQMYCLAV VEVVRRKMFI KHYREWAGAL VKDGKRLYEA EKSKRESFGK
541 LFRKSFLRNR LFRGLDSWPP SFCTQKPRKF DCELPDISLK DLQFLQSFCP SEVQPFLRVP
601 LLCDFEPLHQ HVLALHNLVK AAQSLDEMSQ TITDLLSEQK ASVSQTSPQS ASSPRMESTA
661 GITTTTSPRT PPPLTVQDPL CPAVCPLEEL SPDSIDAHTF DFETIPHPNI EQTIHQVSLD
721 LDSLAESPES DFMSAVNEFV IEENLSSPNP ISDPQSPEMM VESLYSSVIN AIDSRRMQDT
781 NVCGKEDFGD HTSLNVQLER CRVVAQDSHF SIQTIKEDLC HFRTFVQKEQ CDFSNSLKCT
841 AVEIRNIIEK VKCSLEITLK EKHQKELLSL KNEYEGKLDG LIKETEENEN KIKKLKGELV
901 CLEEVLQNKD NEFALVKHEK EAVICLQNEK DQKLLEMENI MHSQNCEIKE LKQSREIVLE
961 DLKKLHVEND EKLQLLRAEL QSLEQSHLKE LEDTLQVRHI QEFEKVMTDH RVSLEELKKE
1021 NQQIINQIQE SHAEIIQEKE KQLQELKLKV SDLSDTRCKL EVELALKEAE TDEIKILLEE
1081 SRAQQKETLK SLLEQETENL RTEISKLNQK IQDNNENYQV GLAELRTLMT IEKDQCISEL
1141 ISRHEEESNI LKAELNKVTS LHNQAFEIEK NLKEQIIELQ SKLDSELSAL ERQKDEKITQ
1201 QEEKYEAIIQ NLEKDRQKLV SSQEQDREQL IQKLNCEKDE AIQTALKEFK LEREVVEKEL
1261 LEKVKHLENQ IAKSPAIDST RGDSSSLVAE LQEKLQEEKA KFLEQLEEQE KRKNEEMQNV
1321 RTSLIAEQQT NFNTVLTREK MRKENIINDL SDKLKSTMQQ QERDKDLIES LSEDRARLLE
1381 EKKKLEEEVS KLRSSSFVPS PYVATAPELY GACAPELPGE SDRSAVETAD EGRVDSAMET
1441 SMMSVQENIH MLSEEKQRIM LLERTLQLKE EENKRLNQRL MSQSMSSVSS RHSEKIAIRD
1501 FQVGDLVLII LDERHDNYVL FTVSPTLYFL HSESLPALDL KPGEGASGAS RRPWVLGKVM
1561 EKEYCQAKKA QNRFKVPLGT KFYRVKAVSW NKKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RB1CC1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.44
- Highest tissue expression
- 49 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 49 nTPM
- cerebral cortex: 41 nTPM
- skeletal muscle: 37 nTPM
- amygdala: 35 nTPM
- testis: 32 nTPM
- tongue: 30 nTPM
Single-cell type
- epicardial cells: 730 nCPM
- neutrophils: 720 nCPM
- cardiomyocytes: 716 nCPM
- endometrial glandular cells: 429 nCPM
- thymic myoid cells: 367 nCPM
- pancreatic acinar cells: 357 nCPM
Immune cell
- basophil: 48 nTPM
- neutrophil: 41 nTPM
- eosinophil: 25 nTPM
- non-classical monocyte: 17 nTPM
- NK-cell: 14 nTPM
- T-reg: 14 nTPM
Brain region
- white matter: 94 nTPM
- amygdala: 85 nTPM
- cerebral cortex: 76 nTPM
- thalamus: 76 nTPM
- medulla oblongata: 63 nTPM
- cerebellum: 62 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RB1CC1.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 234 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.81
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- autophagosome assembly
- autophagy
- autophagy of mitochondrion
- defense response to virus
- extrinsic apoptotic signaling pathway
- glycophagy
- heart development
- innate immune response
- liver development
- negative regulation of cell population proliferation
- negative regulation of extrinsic apoptotic signaling pathway
- pexophagy
- piecemeal microautophagy of the nucleus
- positive regulation of autophagy
- positive regulation of cell size
- positive regulation of JNK cascade
- reticulophagy
- ribophagy
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Autophagy-related protein 11, C-terminal
- Autophagy-related protein 11
- Autophagy-related protein 11
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RB1CC1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RB1CC1 as an antibody target. Whether an autoantibody or antibody against RB1CC1 could matter depends on whether native RB1CC1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RB1CC1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RB1CC1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...